|
|
Company Jiibe
challenge,striving,contented,13:3.006/customer service,customer-focus,internal-focus,6:2.425/demands,balanced,demanding,12:3.887/empowerment,empowering,restraining,3:3.828/innovation,innovating,cautious,8:3.656/rewards & recognition,rewarding,expecting,11:4.263/strategic vision,proactive,reactive,7:3.363/team relations,cooperative,competitive,1:3.188/transparency,transparent,guarded,14:3.092/
|
Jiibe SummaryThis company expects high quality work from employees and rarely needs to shower them with praise, recognition and rewards. It's not how long you're at your desk but what you do when you're there that counts. So go on, sport, call 1-800-BALANCED LIFE and order one. This company avoids risk. If the company wanted you to improvise on how to get results, they'd make you a contestant on "Who's Line Is It Anyway?" Someone's usually looking over your shoulder here because, well, there's already been this great thing invented - it's called the wheel - and they'd rather you not waste time trying to re-invent it.
Click here for the complete Jiibe Summary
Jiibers from Schering-Plough
 | | (hidden) |
|
(Diialog allows its users to remain anonymous. Therefore you will only be able to see the profiles of those that have given you their permission.)  
|
Jobs for Schering-Plough
Click here for more Schering-Plough jobs
Buzz for Schering-Plough
Schering-Plough Schedules Conference Call and Webcast for 2008 ... - PR Newswire (press release) - Schering-Plough Schedules Conference Call and Webcast for 2008 ... PR Newswire (press release), NY - 2 minutes ago 6 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) is scheduled to announce its sales and earnings results for the 2008 fourth quarter and ... (posted 06 Jan 2009 13:05) Corifollitropine alfa: Schering-Plough kondigt aan Europese ... - apothekersnieuws.nl - If approved, corifollitropin alfa would extend Schering-Plough’s leading fertility portfolio, which also includes PUREGON(R). The most frequently reported ... (posted 06 Jan 2009 12:04) Schering-Plough: new infertility drug only partially addresses ... - Trading Markets (press release) - Schering-Plough: new infertility drug only partially addresses ... Trading Markets (press release), CA - 35 minutes ago Following the announcement in July 2008 of the successful completion of the Engage trial, Schering-Plough's corifollitropin alpha (Org-36286) has now been ... (posted 05 Jan 2009 12:34) Schering-Plough spent $500K lobbying in 3Q - Forbes - AP , 01.05.09, 09:22 AM EST Schering-Plough Corp., a major maker of prescription drugs and consumer health products, spent $500000 in the third quarter to ... (posted 05 Jan 2009 08:36)
Click here for more Schering-Plough news
|